Takeda Avoids Another Big Loss In Ill. Actos Cancer Trial

By Lance Duroni (May 15, 2014, 5:45 PM EDT) -- A jury on Thursday cleared Takeda Pharmaceutical Co. Ltd. of liability in the first trial among thousands of Illinois lawsuits blaming the diabetes drug Actos for causing bladder cancer, following a multibillion-dollar verdict against the drugmaker last month in Louisiana.

The 12-member jury — seven men and five women — returned a unanimous verdict in favor of the Japanese drug maker after less than two hours of deliberations in Chicago, ending plaintiff Diane Whitlatch's suit alleging Actos was behind the bladder cancer that killed her husband and that Takeda failed to provide ample warning of the drug's risks.

The four-week bellwether...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!